MOLN
Molecular Partners AG Sponsored ADR · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website molecularpartners.com
- Employees(FY) 175
- ISIN US60853G1067
Performance
-0.56%
1W
-4.81%
1M
-17.0%
3M
-11.94%
6M
-10.05%
YTD
-44.21%
1Y
Profile
Molecular Partners AG operates as a clinical-stage biopharmaceutical company, develops ankyrin proteins for the treatment of oncology and virology diseases. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular age-related macular degeneration, as well as for diabetic macular edema; and ensovibep (MP0420), a multi-specific DARPin therapeutic candidate for the SARS-CoV-2 virus. The company develops MP0310, a DARPin molecule, which activates T-cells and other immune cells; MP0317, that allows tumor-restricted immune-cell CD40 activation for the treatment of fibroblast activation protein (FAP) positive cancers, which is in Phase I clinical trials; MP0317, a tumor-localized immune agonist that activates immune cells in the tumor, which is in Phase I clinical trials; and MP0274, that uses HER2-specific DARPin binding proteins. It also develops MP0533, a CD3 T cell candidate for acute myeloid leukemia; and MP0250 for vascular endothelial growth factor (VEGF)and hepatocyte growth factor. Molecular Partners AG has license and research collaboration agreements with Novartis AG to develop DARPin-conjugated radioligand therapies; as well as other third-party collaborators. It also has a collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics. The company was incorporated in 2004 and is headquartered in Schlieren, Switzerland.
Technical Analysis of MOLN 2024-05-03
Overview:
In analyzing the technical indicators for MOLN over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible stock price movement. By examining key indicators such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to offer valuable insights...
Recent News & Updates
- 2024-04-28 23:00
- 2024-04-18 23:12
Life Science Cares Launches in Switzerland(Globenewswire)
- 2024-04-16 23:12
- 2024-03-25 21:26
- 2024-03-14 04:00
- 2024-03-01 03:00
- 2024-01-07 03:00
- 2024-01-05 03:00
- 2023-12-13 12:00
- 2023-12-09 23:00
- 2023-11-13 12:00
- 2023-11-03 00:00
- 2023-11-01 14:00
- 2023-10-31 14:00
- 2023-10-26 04:00
- 2023-09-12 13:00
- 2023-08-24 04:00
- 2023-07-12 20:06
- 2023-06-26 13:00
- 2023-06-19 00:00
- 2023-06-01 20:59
- 2023-05-25 05:01
- 2023-05-16 04:00
- 2023-05-12 14:00
- 2023-05-11 04:00
- 2023-04-17 13:44
- 2023-04-13 13:00
- 2023-04-03 23:44
- 2023-03-12 21:30
- 2023-03-12 12:22
Page 1 of 4
previousnext